Introduction {#section1-2515841419844087}
============

Syringocystadenocarcinoma papilliferum (SCACP) is a rare malignant sudoriferous gland tumor that is related to its more common, benign counterpart, syringocystadenoma papilliferum (SCAP). Since the original description of SCAP in 1917,^[@bibr1-2515841419844087]^ only 43 cases of SCACP have been described in the literature. To date, only one has appeared in the eyelid.^[@bibr2-2515841419844087]^ SCACP is thought to develop from SCAP, nevus sebaceous, and linear nevus verrucosus lesions.^[@bibr3-2515841419844087]^ However, due to the rarity of this tumor, little is known regarding its etiology and origin.^[@bibr3-2515841419844087]^

In this study, we report the first case of SCACP with orbital involvement. Interestingly, it recurred following exenteration. An informed written consent was obtained from the patient for the publication of medical data and images.

Case report {#section2-2515841419844087}
===========

A 63-year-old man presented with a lesion on the right upper eyelid that had been present for 7 years. The lesion was nodular, measuring 5.0 cm × 7.0 cm, ulcerated, indurated, and erythematous. It involved the lower eyelid ([Figure 1](#fig1-2515841419844087){ref-type="fig"}). The patient had no light perception with the right eye and had a visual acuity of 20/20 on the left. Due to the presence of the tumor over the right eye, his intraocular pressure could not be measured, and it was found to be 18 mmHg on the left.

![Lesion on presentation.](10.1177_2515841419844087-fig1){#fig1-2515841419844087}

The left orbital examination did not reveal any abnormalities. A full examination of his local lymph nodes and lacrimal duct did not reveal any abnormalities. He explained that he did not have any previous therapy for this lesion. He was otherwise systemically well with no relevant family history. He did not have any history of trauma and informed us that he was a farmer by occupation.

A computed tomography (CT) scan of the orbit revealed right anterior orbital invasion with no bony or lacrimal gland involvement ([Figure 2](#fig2-2515841419844087){ref-type="fig"}). A subsequent incisional biopsy revealed squamous cell invaginations extending from the epidermis into the dermis. The invaginations and papillary projections were lined with a bilayer epithelium: the luminal layer was composed of columnar cells with decapitation secretion and the outer layer was composed of small cuboidal cells. These cells had significant nuclear pleomorphism, prominent nucleoli, and increased mitotic activity ([Figure 3](#fig3-2515841419844087){ref-type="fig"}). Immunohistochemical staining demonstrated positivity for epithelial membrane antigen (EMA), Cytokeratin 8/18, and a Cytokeratin cocktail of high and low density ([Figure 3](#fig3-2515841419844087){ref-type="fig"}). It was negative for GCDFP-15 (protein 15 of the fibrocystic disease of the breast), which excluded a lesion of breast origin and carcinoembryonic antigen (CEA). The diagnosis of SCACP was therefore confirmed. A positron emission tomography (PET) scan did not reveal any metastatic spread.

![CT imaging of the lesion at presentation.](10.1177_2515841419844087-fig2){#fig2-2515841419844087}

![Hematoxylin and eosin staining (H&E): (a) the transition between squamous and glandular epithelium (100×). (b) Large areas of superficial epithelium were sphacelated. Glandular invaginations showed a characteristic funnel shape. Papillary structures can be identified inside a dermal cyst (100×). (c) The papillary structures are lined with a stratified atypical epithelium. Micropapillae and secretion by decapitation can be seen (100×). (d) At high power magnification, atypical nuclei are evident. Large atypical nuclear shapes are seen and increased mitotic activity is observed (\*).](10.1177_2515841419844087-fig3){#fig3-2515841419844087}

The patient was treated with exenteration of the right orbit to remove the tumor. After 11 months of follow-up, we noted local recurrence of the original tumor (confirmed with biopsy) in the anophthalmic orbit. There was no associated lymph node enlargement on examination, though the patient refused any further imaging. Radical exenteration with adjuvant radiotherapy has been planned for the patient.

Discussion {#section3-2515841419844087}
==========

SCACP is an extremely rare adnexal neoplasm of the sweat glands and has only been documented 43 times in the literature. It is believed to arise from a malignant transformation of SCAP lesions.^[@bibr4-2515841419844087]^ Clinically, it may present as an asymptomatic long-standing lesion, which may be flat or nodular, cystic, or ulcerated. We performed a literature review of the Medline, EMBASE, and Cochrane databases to characterize the cases previously listed in the literature ([Table 1](#table1-2515841419844087){ref-type="table"}).

###### 

Previous case reports on SCACP.

![](10.1177_2515841419844087-table1)

  Reference                                                   Age   Sex   Location            Size (mm)   Duration          Diagnosis        Association                                                  Follow-up                                                                                       Treatment
  ----------------------------------------------------------- ----- ----- ------------------- ----------- ----------------- ---------------- ------------------------------------------------------------ ----------------------------------------------------------------------------------------------- ---------------------------------------------
  Dissanayake and Salm^[@bibr5-2515841419844087]^             74    F     Scalp               65          30 years          SCACP in situ    SCAP                                                         NED (6.75 years)                                                                                Surgery
                                                              71    F     Back                30          N/A               SCACP invasive   N/A                                                          NED (7 years)                                                                                   Surgery
  Seco Navedo and colleagues^[@bibr6-2515841419844087]^       50    F     Scalp               65          Congenital        SCACP invasive   Nevus sebaceous                                              3 Local lymph node, lymph node metastasis                                                       Surgery + Rt + Ct (NED---2 years)
  Numata and colleagues^[@bibr7-2515841419844087]^            52    F     Chest               130 × 80    20 years          SCACP invasive   N/A                                                          1 Local lymph node, lymph node metastasis                                                       Surgery NED (12 months)
  Bondi and Urso^[@bibr8-2515841419844087]^                   47    M     Scalp               25          N/A               SCACP invasive   N/A                                                          N/A                                                                                             Surgery
  Ishida-Yamamoto and colleagues^[@bibr9-2515841419844087]^   61    M     Perianal            60          10 years          SCACP in situ    N/A                                                          NED (11 months)                                                                                 Surgery
  Arai and colleagues^[@bibr10-2515841419844087]^             64    M     Scalp               35          2 years           SCACP in situ    SCAP                                                         N/A                                                                                             Surgery
  Chi and colleagues^[@bibr11-2515841419844087]^              60    M     Auricle             40 × 10     Since childhood   SCACP invasive   SCAP                                                         NED (72 months)                                                                                 Surgery
  Woestenborghs and colleagues^[@bibr12-2515841419844087]^    81    F     Scalp               15          N/A               SCACP in situ    SCAP                                                         N/A                                                                                             Surgery
  Park and colleagues^[@bibr13-2515841419844087]^             65    M     Suprapubic region   35          2 years           SCACP in situ    N/A                                                          NED (24 months)                                                                                 Surgery
  Langner and Ott^[@bibr14-2515841419844087]^                 83    M     Perianal            15          N/A               SCACP in situ    SCAP                                                         N/A                                                                                             Surgery
  Sroa and colleagues^[@bibr15-2515841419844087]^             77    M     Calf                25          9 years           SCACP invasive   N/A                                                          NED (15 months)                                                                                 Surgery
  Kazakov and colleagues^[@bibr16-2515841419844087]^          56    F     Neck                20          10 years          SCACP in situ    SCAP                                                         NED (9 months)                                                                                  Surgery
                                                              58    M     Forehead            25          25 years          SCACP invasive   SCAP                                                         NED (4 years)                                                                                   Surgery
                                                              46    F     Scalp               35          N/A               SCACP invasive   SCAP                                                         NED (6 years)                                                                                   Surgery
                                                              67    M     Scalp               25          N/A               SCACP in situ    SCAP                                                         NED (2 years)                                                                                   Surgery
                                                              60    F     Scalp               30          \>30 years        SCACP invasive   SCAP                                                         N/A                                                                                             Surgery
                                                              81    M     Scalp               20          N/A               SCACP invasive   SCAP                                                         NED (21 months)                                                                                 Surgery
  Leeborg and colleagues^[@bibr17-2515841419844087]^          86    F     Neck                45          4 months          SCACP invasive   Invasive squamous cell carcinoma                             Local recurrence (18 months)                                                                    Surgery + Rt
  Abrari and Mukherjee^[@bibr18-2515841419844087]^            62    M     Axilla              35          6 months          SCACP invasive   N/A                                                          N/A                                                                                             Surgery
  Aydin and colleagues^[@bibr19-2515841419844087]^            67    M     Scalp               40          Since childhood   SCACP invasive   SCAP                                                         NED (2 years)                                                                                   Surgery
  Hoekzema and colleagues^[@bibr3-2515841419844087]^          83    F     Arm                 30          7 years           SCACP invasive   SCAP nevus verrucosus                                        N/A                                                                                             Surgery
  Hoguet and colleagues^[@bibr20-2515841419844087]^           86    M     Eyelid              4           N/A               SCACP invasive   N/A                                                          NED (3 months)                                                                                  Surgery
  Plant and colleagues^[@bibr21-2515841419844087]^            83    M     Penis               12          N/A               SCACP in situ    N/A                                                          N/A                                                                                             Surgery
  Bakhshi and colleagues^[@bibr22-2515841419844087]^          45    F     Scalp               60 × 30     12 months         N/A              SCAP                                                         NED (12 months)                                                                                 Surgery in situ
  Zhang and colleagues^[@bibr23-2515841419844087]^            75    F     Arm                 15          12 months         SCACP invasive   SCAP                                                         NED (6 months)                                                                                  Surgery
  Peterson and colleagues^[@bibr24-2515841419844087]^         65    M     Scalp               30x30       12 months         SCACP invasive   SCAP                                                         NED                                                                                             Surgery
  Arslan and colleagues^[@bibr2-2515841419844087]^            66    M     Scalp               N/A         20 years          SCACP invasive   SCAP                                                         3 Local lymph node, lymph node metastasis                                                       Surgery + Rt (NED---15 months)
                                                              66    F     Scalp               30          \>12 months       SCACP invasive   N/A                                                          NED (2 years)                                                                                   Surgery
  Castillo and colleagues^[@bibr25-2515841419844087]^         32    F     Scalp               22          N/A               SCACP in situ    N/A                                                          Local recurrence (8 years)                                                                      Surgery
  Paradiso and colleagues^[@bibr26-2515841419844087]^         88    M     Shoulder            15 × 15     N/A               SCACP invasive   N/A                                                          Died from other cause                                                                           N/A
  Shan and colleagues^[@bibr27-2515841419844087]^             93    M     Popliteal fossa     20          \>10 years        N/A              SCAP                                                         NED                                                                                             Surgery
  Mohanty and colleagues^[@bibr28-2515841419844087]^          80    F     Scalp               50          8 years           SCACP in situ    N/A                                                          NED (5 years)                                                                                   Surgery
  Satter and colleagues^[@bibr29-2515841419844087]^           42    M     Scalp               45 × 40     \>1 month         SCACP invasive   SCAP and Nevus sebaceous                                     Lymph node metastasis                                                                           Surgery
  Parekh and colleagues^[@bibr4-2515841419844087]^            74    M     Scalp               20          Since childhood   SCACP invasive   SCAP, nevus sebaceous of Jadassohn, trichoblastoma           Lymph node metastasis                                                                           Surgery
  Chen and colleagues^[@bibr30-2515841419844087]^             60    F     Scalp               28 × 20     12 months         SCACP in situ    Nevus sebaceous                                              N/A                                                                                             Surgery
  Singh and colleagues^[@bibr31-2515841419844087]^            60    F     Back                15 × 10     \>10 years        SCACP in situ    SCACP in situ with macular amyloidosis                       N/A                                                                                             Surgery
  Zhang and colleagues^[@bibr32-2515841419844087]^            26    M     Chest               50          22 years          SCACP in situ    Invasive adenocarcinoma subcutis                             Left axillary lymph node and bilateral lung metastases, DOD 2 months after diagnosis            Surgery + Ct
                                                              47    M     Abdomen             15          23 years          SCACP in situ    N/A                                                          NED (9 years)                                                                                   Surgery
                                                              67    M     Left Axilla         20          6 years           SCACP in situ    Invasive adenocarcinoma subcutis                             N/A                                                                                             Surgery + left axilla lymphadenectomy
                                                              64    M     Scalp               20          1 years           SCACP in situ    Invasive adenocarcinoma in dermis + mucinous metaplasia      Metastases to multiple distant lymph nodes and lung metastases, DOD 34 months after diagnosis   Surgery + Rt
                                                              63    M     Chest               10          10 years          SCACP in situ    Invasive adenocarcinoma in dermis                            NED (36 months)                                                                                 Surgery
                                                              74    M     Chest               20          6 years           SCACP in situ    Invasive adenocarcinoma subcutis                             NED (30 months)                                                                                 Surgery
                                                              63    F     Axilla              50          3 months          SCACP in situ    Invasive adenocarcinoma + invasive squamous cell carcinoma   Widespread subcutaneous metastases, DOD 20 months after diagnosis                               Surgery + right axilla lymphadenectomy
                                                              40    M     Chest               50          5 years           SCACP in situ    Invasive adenocarcinoma subcutis                             NED (14 months)                                                                                 Surgery + bilateral lymphadenectomy + Ct
                                                              29    F     Forehead            15          2 years           SCACP in situ    Invasive squamous cell carcinoma                             NED (10 months)                                                                                 Surgery
                                                              64    M     Axilla              22          10 years          SCACP in situ    Invasive adenocarcinoma subcutis                             NED (3 months)                                                                                  Surgery + right axilla lymphadenectomy + Ct
  Present case                                                63    M     Eyelid              50 × 70     \>6 years         SCACP invasive   SCAP                                                         Local recurrence                                                                                Surgery

Ct, chemotherapy; Rt, radiation therapy; N/A, not available; NED, no evidence of disease; DOD, died of disease.

The tumor appears to affect middle-aged or elderly individuals^[@bibr15-2515841419844087]^ and does not seem to have a gender bias. The most frequent location is the head and neck (53%), with only one case in the eyelid. Other locations where these lesions occur frequently are the back, chest, suprapubic, and perianal regions.

Treatment is based on a complete tumor resection with oncological margins, which is essential for a better prognosis. Mohs surgery has also been successfully used for this purpose.^[@bibr11-2515841419844087]^ Sentinel lymph node biopsy may be feasible in some cases when there is suspicion of lymph spread, although lymphatic spread has been shown to be rare with this tumor (6 of the 42 documented cases; [Table 1](#table1-2515841419844087){ref-type="table"}). Radiotherapy and chemotherapy have also been used rarely, but the experience with these treatments is scarce due to the rarity of the lesion.^[@bibr25-2515841419844087]^

SCACP characteristically presents with squamous cell invaginations extending from the epidermis into the dermis. The invaginations and papillary projections are lined by two-layer epithelium: the luminal layer composed of columnar cells with decapitation secretions and the outer layer composed of small cuboidal cells. The immunohistochemical features of SCACP are still under study, but the most frequently reported markers are CEA,^[@bibr15-2515841419844087],[@bibr20-2515841419844087],[@bibr28-2515841419844087]^ followed by EMA,^[@bibr9-2515841419844087],[@bibr28-2515841419844087]^ GDFP-15,^[@bibr20-2515841419844087],[@bibr28-2515841419844087],[@bibr32-2515841419844087]^ and cytokeratin.^[@bibr11-2515841419844087],[@bibr28-2515841419844087],[@bibr32-2515841419844087]^

Due to its appearance, the differential diagnosis includes other skin tumors such as basal cell carcinoma, squamous cell carcinoma, sebaceous carcinoma, metastatic breast or gastrointestinal adenocarcinomas, and other sweat gland neoplasms.^[@bibr2-2515841419844087],[@bibr20-2515841419844087]^

Of the cases that reported head and neck involvement, 16 (72.72%) were in remission following therapy, 2 (9.09%) had local recurrence, 3 (13.63%) had regional lymphatic invasion, and 1 (4.54%) had distant metastases. Of the reports describing involvement of the thorax, abdomen, and pelvis, 17 (85%) went into remission following therapy, none had local recurrence, 1 (5%) had regional lymphatic invasion and 2 (10%) had distant metastases.

This is the first reported case of SCACP with extension into the anterior orbit. While SCACP is an exceedingly rare tumor, we found that of the reported cases, 16% showed signs of metastasis. It is therefore an important diagnosis to consider when reviewing skin lesions around the orbit. It also encourages us to monitor patients with SCAP more closely as our literature review suggests that SCACP may be more aggressive than previously considered.
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